Abstract

Loss of BRCA2 affects genome stability and is deleterious for cellular survival. Using a genome-wide genetic screen in near-haploid KBM-7 cells, we show that tumor necrosis factor-alpha (TNFα) signaling is a determinant of cell survival upon BRCA2 inactivation. Specifically, inactivation of the TNF receptor (TNFR1) or its downstream effector SAM68 rescues cell death induced by BRCA2 inactivation. BRCA2 inactivation leads to pro-inflammatory cytokine production, including TNFα, and increases sensitivity to TNFα. Enhanced TNFα sensitivity is not restricted to BRCA2 inactivation, as BRCA1 or FANCD2 inactivation, or hydroxyurea treatment also sensitizes cells to TNFα. Mechanistically, BRCA2 inactivation leads to cGAS-positive micronuclei and results in a cell-intrinsic interferon response, as assessed by quantitative mass-spectrometry and gene expression profiling, and requires ASK1 and JNK signaling. Combined, our data reveals that micronuclei induced by loss of BRCA2 instigate a cGAS/STING-mediated interferon response, which encompasses re-wired TNFα signaling and enhances TNFα sensitivity.

Highlights

  • Loss of BRCA2 affects genome stability and is deleterious for cellular survival

  • We find that loss of the tumor necrosis factor-α (TNFα) receptor, or its downstream signaling component SAM68, rescues cytotoxicity induced by BRCA2 inactivation in KBM-7 cells

  • Our results describe a mechanism by which autocrine TNFα signaling, induced by cGAS/STING signaling upon loss of the BRCA2 tumorsuppressor gene, limits tumor cell viability

Read more

Summary

Introduction

Loss of BRCA2 affects genome stability and is deleterious for cellular survival. Using a genome-wide genetic screen in near-haploid KBM-7 cells, we show that tumor necrosis factor-alpha (TNFα) signaling is a determinant of cell survival upon BRCA2 inactivation. Homozygous hypomorphic mutations of the DNA repair genes BRCA1 and BRCA2 are associated with development of Fanconi anemia[3,4], whereas heterozygous BRCA1 or BRCA2 mutations predispose affected individuals to earlyonset breast and ovarian cancer[5,6,7]. Both BRCA1 and BRCA2 are key players in DNA damage repair through homologous recombination (HR)[8]. BRCA2 controls the loading of the RAD51 recombinase onto resected DNA ends[9]

Methods
Results
Conclusion
Full Text
Paper version not known

Talk to us

Join us for a 30 min session where you can share your feedback and ask us any queries you have

Schedule a call

Disclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.